Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

neoplasm of uncertain malignant potential

Known as: Neoplasm of Borderline Malignancy, Neoplasm of Low Malignant Potential, NEOPLASMS OF UNCERTAIN BEHAVIOR 
A neoplasm displaying morphologic, phenotypic, or genotypic characteristics that are clearly not benign but do not permit the establishment of a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The development of guidelines recommendations is one of the core activities of the European Society for Medical Oncology (ESMO… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Metabolites are the end products of cellular regulatory processes, and their levels can be regarded as the ultimate response of… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE Mutations of BRAF, a downstream mediator of K-RAS, have been described in serous borderline tumors of the ovary. Data… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The infrequent association of serous borderline tumors (SBTs) with invasive serous carcinoma has led to the view that SBTs are… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The natural history, classification, and nomenclature of ovarian serous tumors of low malignant potential (S-LMP) (serous tumors… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Molecular genetic changes that are associated with the initiating stage of tumor development are important in tumorigenesis… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
With the exception of benign cystadenomas, mucinous ovarian tumors are rare and heterogeneous neoplasms. They have been… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Borderline tumors account for 10% to 20% of epithelial ovarian tumors, and their prognosis is outstanding; nevertheless… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
  • K. Lee, R. Scully
  • The American journal of surgical pathology
  • 2000
  • Corpus ID: 36588302
Mucinous ovarian neoplasms other than cystadenomas and adenofibromas have been classified as either borderline tumors or… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Poor outcome in serous borderline tumors (SBT) of the ovary is limited to patients with advanced stage disease. This study was… Expand
Is this relevant?